These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 36336

  • 21. Managing antipsychotic-induced tardive dyskinesia.
    Gardos G.
    Drug Saf; 1999 Feb; 20(2):187-93. PubMed ID: 10082074
    [Abstract] [Full Text] [Related]

  • 22. Benzodiazepines for neuroleptic-induced tardive dyskinesia.
    Bhoopathi PS, Soares-Weiser K.
    Cochrane Database Syst Rev; 2006 Jul 19; (3):CD000205. PubMed ID: 16855954
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. [Occurrence of tardive dyskinesia during neuroleptic treatment].
    Fanget F, Henry E, Aimard G.
    Presse Med; 1986 Dec 06; 15(43):2147-50. PubMed ID: 2884657
    [Abstract] [Full Text] [Related]

  • 25. The present status of tardive dyskinesia and akathisia in the treatment of schizophrenia.
    Barnes TR.
    Psychiatr Dev; 1987 Dec 06; 5(4):301-19. PubMed ID: 2895467
    [Abstract] [Full Text] [Related]

  • 26. Tardive dyskinesia presenting as a psychosis.
    Asnis GM, Nathan RS, Davies SO, Halbreich U.
    J Nerv Ment Dis; 1979 Dec 06; 167(12):762-3. PubMed ID: 41884
    [Abstract] [Full Text] [Related]

  • 27. Tardive dyskinesia with schizophrenic relapse.
    Jawed SH, Singh I.
    J Ment Defic Res; 1989 Aug 06; 33 ( Pt 4)():331-4. PubMed ID: 2570160
    [Abstract] [Full Text] [Related]

  • 28. Cholinergic medication for neuroleptic-induced tardive dyskinesia.
    Tammenmaa IA, McGrath JJ, Sailas E, Soares-Weiser K.
    Cochrane Database Syst Rev; 2002 Aug 06; (3):CD000207. PubMed ID: 12137608
    [Abstract] [Full Text] [Related]

  • 29. The treatment of tardive dyskinesia and tardive dystonia.
    Simpson GM.
    J Clin Psychiatry; 2000 Aug 06; 61 Suppl 4():39-44. PubMed ID: 10739330
    [Abstract] [Full Text] [Related]

  • 30. Comparison of severe and mild tardive dyskinesia: implications for etiology.
    Gardos G, Cole JO, Schniebolk S, Salomon M.
    J Clin Psychiatry; 1987 Sep 06; 48(9):359-62. PubMed ID: 2887550
    [Abstract] [Full Text] [Related]

  • 31. Prevention and management of tardive dyskinesia.
    Jeste DV, Wyatt RJ.
    J Clin Psychiatry; 1985 Apr 06; 46(4 Pt 2):14-8. PubMed ID: 2858473
    [Abstract] [Full Text] [Related]

  • 32. Tardive dystonia associated with low-dose of amisulpride: a case report.
    Sevincok L, Balci V, Akyildiz U.
    J Clin Psychopharmacol; 2008 Oct 06; 28(5):573-4. PubMed ID: 18794659
    [No Abstract] [Full Text] [Related]

  • 33. Clozapine-related tardive dyskinesia.
    Davé M.
    Biol Psychiatry; 1994 Jun 01; 35(11):886-7. PubMed ID: 8054412
    [No Abstract] [Full Text] [Related]

  • 34. Valbenazine granted breakthrough drug status for treating tardive dyskinesia.
    Müller T.
    Expert Opin Investig Drugs; 2015 Jun 01; 24(6):737-42. PubMed ID: 25809133
    [Abstract] [Full Text] [Related]

  • 35. Management of conventional antipsychotic-induced tardive dyskinesia.
    Margolese HC, Ferreri F.
    J Psychiatry Neurosci; 2007 Jan 01; 32(1):72. PubMed ID: 17245473
    [No Abstract] [Full Text] [Related]

  • 36. Reversibility of long-term tardive dyskinesia associated with antiparkinsonian medication: a case report.
    Good MI.
    Am J Psychiatry; 1981 Aug 01; 138(8):1112-3. PubMed ID: 6114643
    [Abstract] [Full Text] [Related]

  • 37. Tardive dyskinesia.
    Casey DE.
    West J Med; 1990 Nov 01; 153(5):535-41. PubMed ID: 1979705
    [Abstract] [Full Text] [Related]

  • 38. Use of the selective serotonin 3 receptor antagonist ondansetron in the treatment of neuroleptic-induced tardive dyskinesia.
    Sirota P, Mosheva T, Shabtay H, Giladi N, Korczyn AD.
    Am J Psychiatry; 2000 Feb 01; 157(2):287-9. PubMed ID: 10671405
    [Abstract] [Full Text] [Related]

  • 39. Can atypical antipsychotics improve tardive dyskinesia associated with other atypical antipsychotics? Case report and brief review of the literature.
    Peritogiannis V, Tsouli S.
    J Psychopharmacol; 2010 Jul 01; 24(7):1121-5. PubMed ID: 19395427
    [Abstract] [Full Text] [Related]

  • 40. Calcium channel blockers for neuroleptic-induced tardive dyskinesia.
    Essali A, Deirawan H, Soares-Weiser K, Adams CE.
    Cochrane Database Syst Rev; 2011 Nov 09; (11):CD000206. PubMed ID: 22071797
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.